132 related articles for article (PubMed ID: 11716093)
1. Characterization of antibody responses to combinations of a dengue-2 DNA and dengue-2 recombinant subunit vaccine.
Simmons M; Murphy GS; Kochel T; Raviprakash K; Hayes CG
Am J Trop Med Hyg; 2001 Nov; 65(5):420-6. PubMed ID: 11716093
[TBL] [Abstract][Full Text] [Related]
2. Characterization of antibody responses to combinations of a dengue virus type 2 DNA vaccine and two dengue virus type 2 protein vaccines in rhesus macaques.
Simmons M; Porter KR; Hayes CG; Vaughn DW; Putnak R
J Virol; 2006 Oct; 80(19):9577-85. PubMed ID: 16973561
[TBL] [Abstract][Full Text] [Related]
3. Short report: Antibody responses of mice immunized with a tetravalent dengue recombinant protein subunit vaccine.
Simmons M; Murphy GS; Hayes CG
Am J Trop Med Hyg; 2001 Aug; 65(2):159-61. PubMed ID: 11508393
[TBL] [Abstract][Full Text] [Related]
4. Murine immunoglobulin G subclass responses following immunization with live dengue virus or a recombinant dengue envelope protein.
Smucny JJ; Kelly EP; Macarthy PO; King AD
Am J Trop Med Hyg; 1995 Oct; 53(4):432-7. PubMed ID: 7485699
[TBL] [Abstract][Full Text] [Related]
5. DNA priming E and NS1 constructs--homologous proteins boosting immunization strategy to improve immune response against dengue in mice.
Mellado-Sánchez G; García-Cordero J; Luria-Pérez R; Lázaro-Olan L; Santos-Argumedo L; Gutiérrez-Castañeda B; Estrada-García I; Cedillo-Barrón L
Viral Immunol; 2005; 18(4):709-21. PubMed ID: 16359237
[TBL] [Abstract][Full Text] [Related]
6. Tetravalent neutralizing antibody response against four dengue serotypes by a single chimeric dengue envelope antigen.
Apt D; Raviprakash K; Brinkman A; Semyonov A; Yang S; Skinner C; Diehl L; Lyons R; Porter K; Punnonen J
Vaccine; 2006 Jan; 24(3):335-44. PubMed ID: 16125280
[TBL] [Abstract][Full Text] [Related]
7. Neutralizing antibodies respond to a bivalent dengue DNA vaccine or/and a recombinant bivalent antigen.
Zhang ZS; Weng YW; Huang HL; Zhang JM; Yan YS
Mol Med Rep; 2015 Feb; 11(2):1009-16. PubMed ID: 25371092
[TBL] [Abstract][Full Text] [Related]
8. Multiple antigenic peptides as vaccine platform for the induction of humoral responses against dengue-2 virus.
Amexis G; Young NS
Viral Immunol; 2007 Dec; 20(4):657-63. PubMed ID: 18158738
[TBL] [Abstract][Full Text] [Related]
9. Simultaneous immunization with DNA and protein vaccines against Japanese encephalitis or dengue synergistically increases their own abilities to induce neutralizing antibody in mice.
Konishi E; Terazawa A; Imoto J
Vaccine; 2003 May; 21(17-18):1826-32. PubMed ID: 12706666
[TBL] [Abstract][Full Text] [Related]
10. A dengue virus serotype-1 DNA vaccine induces virus neutralizing antibodies and provides protection from viral challenge in Aotus monkeys.
Kochel TJ; Raviprakash K; Hayes CG; Watts DM; Russell KL; Gozalo AS; Phillips IA; Ewing DF; Murphy GS; Porter KR
Vaccine; 2000 Jul; 18(27):3166-73. PubMed ID: 10856796
[TBL] [Abstract][Full Text] [Related]
11. Evaluation in Mice of the Immunogenicity of a Tetravalent Subunit Vaccine Candidate Against Dengue Virus Using Mucosal and Parenteral Immunization Routes.
Lazo Vázquez L; Gil González L; Marcos López E; Pérez Fuentes Y; Cervetto de Armas L; Brown Richards E; Valdés Prado I; Suzarte Portal E; Cobas Acosta K; Yaugel Novoa M; Romero Fernández Y; Guillén Nieto G; Hermida Cruz L
Viral Immunol; 2017 Jun; 30(5):350-358. PubMed ID: 28418786
[TBL] [Abstract][Full Text] [Related]
12. Evaluation of chimeric DNA vaccines consisting of premembrane and envelope genes of Japanese encephalitis and dengue viruses as a strategy for reducing induction of dengue virus infection-enhancing antibody response.
Sjatha F; Kuwahara M; Sudiro TM; Kameoka M; Konishi E
Microbiol Immunol; 2014 Feb; 58(2):126-34. PubMed ID: 24372832
[TBL] [Abstract][Full Text] [Related]
13. Induction of neutralizing antibodies and T cell responses by dengue virus type 2 envelope domain III encoded by plasmid and adenoviral vectors.
Khanam S; Khanna N; Swaminathan S
Vaccine; 2006 Oct; 24(42-43):6513-25. PubMed ID: 16860446
[TBL] [Abstract][Full Text] [Related]
14. High-level expression of recombinant dengue virus type 2 envelope domain III protein and induction of neutralizing antibodies in BALB/C mice.
Zhang ZS; Yan YS; Weng YW; Huang HL; Li SQ; He S; Zhang JM
J Virol Methods; 2007 Aug; 143(2):125-31. PubMed ID: 17532481
[TBL] [Abstract][Full Text] [Related]
15. Pichia pastoris-expressed dengue virus type 2 envelope domain III elicits virus-neutralizing antibodies.
Batra G; Raut R; Dahiya S; Kamran N; Swaminathan S; Khanna N
J Virol Methods; 2010 Jul; 167(1):10-6. PubMed ID: 20211204
[TBL] [Abstract][Full Text] [Related]
16. Synergistic neutralizing antibody response to a dengue virus type 2 DNA vaccine by incorporation of lysosome-associated membrane protein sequences and use of plasmid expressing GM-CSF.
Raviprakash K; Marques E; Ewing D; Lu Y; Phillips I; Porter KR; Kochel TJ; August TJ; Hayes CG; Murphy GS
Virology; 2001 Nov; 290(1):74-82. PubMed ID: 11883007
[TBL] [Abstract][Full Text] [Related]
17. Carboxy-terminally truncated Dengue 4 virus envelope glycoprotein expressed in Pichia pastoris induced neutralizing antibodies and resistance to Dengue 4 virus challenge in mice.
Muné M; Rodríguez R; Ramírez R; Soto Y; Sierra B; Rodríguez Roche R; Marquez G; Garcia J; Guillén G; Guzmán MG
Arch Virol; 2003 Nov; 148(11):2267-73. PubMed ID: 14579183
[TBL] [Abstract][Full Text] [Related]
18. A DNA vaccine expressing dengue type 2 virus premembrane and envelope genes induces neutralizing antibody and memory B cells in mice.
Konishi E; Yamaoka M; Kurane I; Mason PW
Vaccine; 2000 Jan; 18(11-12):1133-9. PubMed ID: 10590335
[TBL] [Abstract][Full Text] [Related]
19. Induction of protective immunity against Dengue virus type 2: comparison of candidate live attenuated and recombinant vaccines.
Velzing J; Groen J; Drouet MT; van Amerongen G; Copra C; Osterhaus AD; Deubel V
Vaccine; 1999 Mar; 17(11-12):1312-20. PubMed ID: 10195766
[TBL] [Abstract][Full Text] [Related]
20. Expression of enhancing-activity-free neutralizing antibody against dengue type 1 virus in plasmid-inoculated mice.
Yamanaka A; Pitaksajjakul P; Ramasoota P; Konishi E
Vaccine; 2015 Nov; 33(45):6070-7. PubMed ID: 26259543
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
